The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met(+) Hepatocellular Carcinoma

BACKGROUND: c-Met, a high-affinity receptor for Hepatocyte Growth Factor (HGF), plays a critical role in tumor growth, invasion, and metastasis. Hepatocellular carcinoma (HCC) patients with activated HGF/c-Met signaling have a significantly worse prognosis. Targeted therapies using c-Met tyrosine ki...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinway, Steven N., Dang, Hien, You, Hanning, Rountree, C. Bart, Ding, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441360/
https://www.ncbi.nlm.nih.gov/pubmed/26000702
http://dx.doi.org/10.1371/journal.pone.0128159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441360/
https://www.ncbi.nlm.nih.gov/pubmed/26000702
http://dx.doi.org/10.1371/journal.pone.0128159

Ejemplares similares